NOVEL SYNTHESIS OF MYO-INOSITOL PHOSPHATES

Abstract: Provided herein are novel syntheses of the phosphate-based inositol derivatives 1-O-[(+)-menthoxycarbonyl]-6-O-benzyl-2,3:4,5-di-O-isopropylidene-myo-inositol (D4P), D-myo-inositol 1,4,5-triphosphate (D-IP3), 6-O-benzyl-2,3:4,5-di-O-isopropylidene-myo-inositol H-phosphonate (3-HP) and L-myo-inositol 1,4,5-triphosphate (L-IP3). These syntheses employ fewer column chromatography steps for the isolation of intermediates than do prior art syntheses, and hence, are more convenient, economical and efficient than are the previously known synthetic methods.

Description: NOVEL SYNTHESIS OF MYO-INOSITOL PHOSPHATES Field of the Invention This invention is directed to the synthesis of phosphate-based inositol derivatives by rapid, economic and efficient processes. Background of the Invention Many signaling molecules, such as hormones and neurotransmitters, exert effects on their target cell by binding to a receptor in the cell's membranes. Following binding, presence of the signaling molecule on its receptor is translated into an effect within the target cell by one or more molecules located within the membrane. The compound responsible for transducing the effect of many signaling molecules is believed to be phosphatidylinositol 4,5-bisphosphate ("PIP 2 "). Hydrolysis of PIP 2 , following binding of a signalling molecule to its receptor, results in the formation of D-myo-inositol 1 ,4,5-trisphosphate ("D-IP3") and diacylglycerol. D-IP3 causes calcium to be released from intracellular, nonmitochondrial stores; increased intracellular calcium levels, in turn, result in a variety of responses within the cell, such as muscle contraction, cell aggregation and thromboxane B release. Moreover, diacylglycerol, together with phosphatidylserine and calcium, activates protein kinase C. PKC is well known to phosphorylate a number of proteins involved in the regulation of cell metabolism. Accordingly, D-IP3 and other phosphate-based inositol derivatives are useful in a variety of ways, including elucidative study of the pathways and mecahnisms by which external signals affect intracellular processes. For example, isolation and identification of intracellular D-IP3 receptors is helpful in illuminating the role of calcium mobilization in various physiological and pathological processes, as well as for the development of pharmacological agents capable of modulating the effects of calcium mobilization. Synthesis of D-IP3 has previously been reported (see S. Ozaki et al., 1986). However, Ozaki's process requires separation of several inositol diastereomers by column chromatography, a costly, inefficient and commercially impracticable process requiring silica gel that costs about $150/kilogram. Although others (see J. Gigg et al., 1985; R. de la Pradilla et al., 1990; N. Noda et al., 1990; Chen et al., U.S. Patent No. 5,260,472) have reported D-IP3 synthesis via fewer intermediates than arise in Ozaki's process, their methods still require multiple chromatographic separations, and/or reactants that are not commercially available This invention provides rapid, convenient and economical synthesis of the enantiomencally pure inositol derivatives D-IP 3 and L-IP3 employing minimal use of chromatography Reaction intermediates are generally isolated by crystallization, and the reagents used are all commercially available, at relatively low cost Moreover, one of the intermediates made during the synthetic process can be converted into a useful precursor for the synthesis of mositol-based lipids and inositol analogs The ιnosιtol-/-/-phosphonate 3-HP provided can be used to prepare various phosphatidy nositols SUMMARY OF THE INVENTION This invention provides rapid, convenient and economical synthesis of 1-0-[(+)- menthoxycarbonyl]-6-0-benzy 1-2,3 4,5-dι-O-ιsopropylιdene-myo-ιnosιtol ("D4P"), D-myo- inositol 1,4,5-trιsphosphate ("D-IP3"), inositol 6-0-benzyl-2,34,5-dι-0-ιsopropylιdene-A77yo- inositol H-phosphonate ("3-HP") and L-myo-inositol 1 ,4,5-trιsphosphate ("L-IP 3 ") The syntheses require fewer chromatographic isolation steps than do previously known reaction schemes D4P is synthesized according to the practice of this invention from D-myo-inositol via the intermediates (±)-2,3 4,5-dι-O-ιsopropylιdene-myo-ιnosιtol ("(+)-2"), (±)-6-0- benzyl-2,3 4,5-dι-0-ιsopropylιdene ("(±)-3") and 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl- 2,3 4,5-dι-O-ιsopropylιdene-myo-ιnosιtol ("4P"), following which D4P is isolated from the racemic 4P by crystallization with methanol D-IP3 is made from D4P via the intermediates (+)-6-0-benzyl-2,3-0-ιsopropylιdene myo-inositol and 6-0-benzyl-2,3-0- isopropylidene-myo-inositol 1 ,4,5-tπs(dιbenzyl phosphate) Chromatography is employed during this synthesis only for the isolation of 6-0-benzyl-2,3-0-ιsopropylιdene-myo-ιnosιtol 1 , 4, 5-trιs(dιbenzyl phosphate) 3-HP is made from D-4P via the intermediate (-)-6-0-benzyl-2,3-0- isopropylidene-myo-mositol L-IP3 is made via the compounds (±)-6-0-benzyl-2,3 4,5-dι- 0-ιsopropylιdene-myo-ιnosιtol ((±)-3), 3-0-[(+)-menthoxycarbonyl]-4-0-benzyl-1 ,2 5,6-dι- 0-ιsopropylιdene-myo-ιnosιtol (4M), 4-0-benzyl-1 ,2-0-ιsopropylιdene-/τ?yo-ιnosιtol 3,5,6- tris(dibenzyl phosphate) and 4-0-benzyl-1 ,2-0-isopropylidene-myo-inositol 3,5,6- tris(dibenzyl phosphate). Chromatography is exployed during this synthesis only for the isolation of 4-0-benzyl-1 ,2-0-isopropylidene-myo-inositol 3,5,6-tris(dibenzyl phosphate). DETAILED DESCRIPTION OF THE INVENTION Following are abbreviations, and the full names of chemical compounds designated by the abbreviations, which may be found in this application: 1-0-[(+)- menthoxycarbonyl]-6-0-benzyl-2,3:4,5-di-0-isopropylidene-myo-inositol: D4P; (+)-2, 3:4,5- di-O-isopropylidene-myo-inositol: (±)-2; (±)-6-0-benzyl-2,3:4,5-di-0-isopropylidene-myo- inositol: (±)-3; rac-1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3:4,5-di-0-isopropylidene- myo-inositol: 4P; D-myo-inositol 1 ,4,5-trisphosphate: D-IP3; m-chloroperoxybenzoic acid: mCPBA; inositol 6-0-benzyl-2,3:4,5-di-0-isopropylidene-myo-inositol H-phosphonate: 3- HP; L-myo-inositol 1 ,4,5-trisphosphate: L-IP 3 ; and, 3-0-[(+)-menthoxycarbonyl]-4-0- benzyl-1 ,2:5,6-di-0-isopropylidene-myo-inositol: 4M. This invention provides in general the synthesis of phosphoinositol derivatives, using H-phosphonates as intermediates and (+)-menthyl chloroformate to separate the various inositol derivatives. More specifically, a method is described of preparing D-1-0- [(+)-menthoxycarbonyl]-6-0-benzyl-2,3:4,5-di-0-isopropylidene-myo-inositol ("D-4P") (see scheme 1 , hereinbelow). Also provided herein is a method of preparing enantiomerically pure D-myo-inositol 1 ,4,5-trisphosphate ("D-IP3") (see scheme 1 , hereinbelow). The first step in the process of preparing D-4P involves conversion of yo-inositol to (±)-2,3:4,5-di-0-isopropylidene-myo-inositol ("(±)-2") by acetonation of myo-inositol so as to give (±)-2,3-0-isopropylidene-myo-inositol, and acetonation of this product so as to give (±)-2,3:4,5-di-0-isopropylidene-myo-inositol. Next, this (±)-2 is converted to (±)-6-0- benzyl-2,3:4,5-di-0-isopropylidene ("(+)-3)") by stannylation of (±)-2,3:4,5-di-0- isopropylidene-myo-inositol, followed by benzylation of this product so as to give (±)-6- benzyl-2,3:4,5-di-0-isopropylidene. Benzylation is accomplished by a number of means well known to ordinarily skilled artisans including, without limitation: reaction using cesium fluoride in benzyl bromide; sonication with silver oxide in benzyl bromide; phase transfer catalysis using sodium hydroxide in benzyl bromide; and, reaction with thallous ethoxide in benzyl bromide. Preferably, benzylation is by reaction with cesium fluoride and benzyl bromide. (±)-3 is then converted to rac-1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3:4,5-di- O-isopropylidene-myo-inositol ("4P"), for example, by acylation of (±)-3 with menthyl chloroformate. D-4P is isolated from the racemate 4-P product, for example, using methanol. Proton and phosphorous NMR spectra of these compounds, as well as the other compounds made herein, have been conducted by standard means and are consistent with the predicted structures (for the spectra of the compound (±)-3, see Chung and Ryu, 1994)). The first step in the process of preparing enantiomerically pure D-myo-inositol 1 ,4,5-trisphosphate ("D-IP 3 ") (see scheme 1 , hereinbelow) involves conversion of (+)-6-0- benzyl-2,3-0-isopropylidene-myo-inositol by hydrolysis of the D4P, e.g., with pyridinium p- toluenesulfonate, so as to give 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3-0- isopropylidene-myo-inositol. This product is subjected to alkaline hydrolysis so as to give (+)-6-0-benzyl-2,3-0-isopropylidene-myo-inositol. The product of this step is then converted to 6-0-benzyl-2,3-0-isopropylidene-myo-inositol 1,4,5-tris(dibenzyl phosphate) by first phosphorylating (+)-6-0-benzyl-2,3-0-isopropylidene-myo-inositol so as to give 6- 0-benzyl-2,3-0-isopropyiidene-myo-inositol 1 ,4,5-tris(dibenzyl phosphite). Phosphorylation can be by any means generally accepted in the art for attaching phosphorous atoms to compounds; preferably, this phosphorylation step is conducted with Λ/,Λ/-diisopropyl-di-benzyl phosphoramidite. Following phosphorylation, the phosphite is oxidized in situ, e.g., with m- chloroperoxybenzoic acid ("mCPBA"), so as to give 6-0-benzyl-2,3-0-isopropylidene- myo-inositol 1 ,4,5-tris(dibenzyl phosphate). 6-0-Benzyl-2,3-0-isopropylidene-myo- inositol 1 ,4,5-tris(dibenzyl phosphate) is isolated from the resulting phosphate, for example, using Si0 2 chromatography. D-IP 3 is then formed by hydrogenolysis of 6-0- benzyl-2,3-0-isopropylidene-myo-inositol 1 ,4,5-tris(dibenzyl phosphate), for example, using palladium on charcoal, so as to give 2,3-O-isopropylidene-myo-inositol 1 ,4,5- trisphosphate. Acidification of this product, e.g., with acetic acid, gives D-myo-inositol 1 ,4,5-trisphosphate. Further provided herein is a method of preparing 6-0-benzyl-2,3:4,5-di-0- isopropylidene-myo-inositol H-phosphonate ("3-HP") (see scheme 3, hereinbelow). This method involves hydrolysis of D4P with potassium carbonate in methanol so as to give (-)- 6-0-benzyl-2,3-0-isopropylidene-myo-inositol ("(-)-3"), followed by conversion of the product to 3-HP using PCI 3 and imidazole. Still further provided herein is a method of preparing enantiomerically pure L-myo- inositol 1 ,4,5-trisphosphate (L-IP3) (see scheme 2 hereinbelow). First, (±)-6-0-benzyl- 2,3:4,5-di-0-isopropylidene ("(±)-3") is converted to rac-3-0-[(-)-menthoxycarbonyl]-4-0- benzyl-1 ,2:5,6-di-0-isopropylidene-myo-inositol ("4M"), preferably, but not necessarily, by acylation with (-)-menthyl chloroformate. L4M is crystallized from the product of this reaction, e.g., with methanol. It is then converted to 4-0-benzyl-1 ,2-0-isopropylidene- myo-inositol 3,5,6-tris(dibenzyl phosphate) by phosphitylation of 4-0-benzyl-1 ,2- isopropylidene-myo-inositol, e.g., with Λ/,Λ/-diisopropyl-dibenzyl phosphoramidite so as to give 4-0-benzyl-1 ,2-0-isopropylidene-myo-inositol 3,5,6-tris(dibenzyl phosphite). In situ oxidation of the product, e.g., with m-chloroperoxybenzoic acid, gives 4-0-benzyl-1 ,2-0- isopropylidene-myo-inositol 3,5,6-tris(dibenzyl phosphate), which is then isolated by a number of means, including Si0 2 chromatography. L-myo-inositol 1 ,4,5-trisphosphate is then formed by hydrogenolysis of 4-0-benzyl-1 ,2-0-isopropylidene-myo-inositol 3,5,6- tris(dibenzyl phosphate), e.g., using palladium on charcoal, so as to give 1 ,2-0- isopropylidene-myo-inositol 3,5,6-trisphosphate. This product is then acidified with acetic acid so as to give L-myo-inositol 3,5,6-trisphosphate. This invention will be better understood from the following examples. However, those of ordinary skill in the art will readily understand that the examples are merely illustrative of the invention as defined in the claims which follow thereafter. The description given herein includes such modifications to its compounds, reactants, reaction schemes and other provisions, that are obvious to ordinarily skilled artisans given the teachings of this invention. 1 ) α n-DUtyltiπ oxide 2) CsF. BnBr ( (±)-2 (±)-3 D4P L4P 1)PPTS 1) H,, PdtC 2)K 2 C Q 3 22i)AAecOOHH D-fP. P 1 = -P{0)(OBπ) 2 ; Bn = -C^CgHg: MnC ■ (+)-meπthy1 Scheme 2: Synthesis of L-IP 3 (±>-3 D4M L4M L-IP, Scheme 3: Synthesis of 3HP 1) PCI 3 , imidazole, tnettiylamine 2) Et 3 NH + HCθ3 D4P (from scheme 1 ) (-)-3 3HP MnC = (+)-rneπthyl Bn ~ - CH j CgHc HP 4 1 -pyrβnβbutaπol 4-0-(1 '-pyrene-1 -butyl)phosphory| D-myo-inositol EXAMPLES Example 1 Chromatography All flash and Sι0 2 chromatography was conducted using Kieselgel™ 60 (EM Science) All compounds made were judged to be pure using thin layer chromatography (Kieselgel™ 60, impregnated on aluminum sheets) Example 2 Synthesis of D4P /Wyo-ιnosιtol was converted (see scheme 1) to (±)-2,34,5-dι-O-ιsopropylιdene- myo-inositol according to the methods of Gigg et al or de la Pradilla et al (the contents of which are incorporated herein by reference) Regioselective monobenzylation of (±)-2 was accomplished via an O-stannylated intermediate to give (±)-6-0-benzyl-2,3 4,5-dι-O- isopropy dene-myo-inositol ("(±)-3"), readily purified by flash chromatography (hexane ethyl acetate 4 1), in 60% yield (±)-3 was converted to racemic 4P using (+)- menthyl chloroformate D4P (mp 128-131°C ) was isolated from the racemic 4P by recrystallization in methanol Example 3 Synthesis of D-IP 2 Selective hydrolysis of the transketal of D4P (see scheme 1) with pyπdinium p- toluenesulfonate, followed by alkaline hydrolysis of the menthyl carbonate in methanol, gave the triol (+)-6-0-benzyl-2,3-0-ιsopropylιdene-myo-ιnosιtol (5, [α] D 2 °c +21° (c 0 43, CHCI3), lit (de la Pradilla et al ) [α] D +15° (c 0 6, CH3OH)) in 40% yield after purification by flash chromatography The triol was also crystallized in 32% yield from the crude reaction mixture using hexane ethyl acetate (4 1 ) Phosphitylation of the triol with N,N- dnsopropyldibenzyl phosphoramidite (Fraser-Reid reagent), followed by in situ oxidation with mCPBA, gave 6-0-benzyl-2,3-0-ιsopropylιdene-myo-ιnosιtol in 92% yield, after purification by flash chromatography Hydrogenolysis gave 6-0-benzyl-2,3-0- isopropy dene-myo-inositol over palladium on charcoal, followed by acidification with acetic acid, gave D-IP 3 in quantitative yield ([α] D 24 ° -20° (c 0 05, H 2 0, pH 9), lit (Liu et al ) ([α] D -30° (c 0 5, H 2 0, pH 9 5)) Example 4 Synthesis of L-IP 2 Reaction of (+)-3, prepared as described in Example 1 hereinabove, with (-)- menthyl chloroformate (see scheme 2), followed by crystallization with methanol, gave enantiomericaliy pure L4M (mp 130-131 °C), the enantiomer of D4P. Following the same scheme as set forth in Example 3 hereinabove, but using L4M as the starting material instead of D4P (see scheme 2), gave L-IP3 in similar yield (([α] D 24 ° c +17° (c 0.30, H 2 0, pH 10)). Example 5 Synthesis of 3-HP Hydrolysis of D4P with potassium carbonate (see scheme 3) in methanol gave (-)- 3 ([ ] D 2 ° c -17.4° (c 1.69, CHCI3); lit. (Chen et al.): ([α] D -16° (c 0.9, CHCI3)) in quantitative yield after column chromatography (hexane:ethyl acetate 4:1). Conversion to the corresponding H-phosphonate with PCI3 and imidazole gave the product 3-HP in 70% yield. 3-HP was a colorless liquid that was stable for several months at -20°C.

Claims: What is claimed is: 1. A method of preparing 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3:4,5-di-0- isopropylidene-myo-inositol which comprises: (a) converting D-myo-inositol to (±)-2,3:4,5-di-0-isopropylidene-myo-inositol by the steps of: (i) acetonation of myo-inositol so as to give (±)-2,3-0-isopropylidene-myo- inositol; and, (ii) acetonation of the product of step (i) so as to give to (±)-2,3:4,5-di-0- isopropylidene-myo-inositol; (b) converting the product of step (a) to (±)-6-0-benzyl-2,3:4,5-di-0- isopropylidene by the steps of: (i) stannylation of (±)-2,3:4,5-di-0-isopropylidene-myo-inositol; and, (ii) benzylation of the product of step (i) so as to give (±)-6-0-benzyl-2, 3:4,5- di-O-isopropylidene myo-inositol; (c) converting the product of step (b) to 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl- 2,3:4,5-di-0-isopropylidene-myo-inositol; and, (d) isolation of 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3:4,5-di-0- isopropylidene-myo-inositol from the product of step (c). 2. The method of claim 1 , wherein the benzylation of step (b)(ii) is by reaction with cesium fluoride and benzyl bromide. 3. The method of claim 1 , wherein the conversion of step (c) is by acylation with (+)- menthyl chloroformate. 4. The method of claim 1 , wherein 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2, 3:4,5- di-O-isopropylidene-myo-inositol is recrystallized in step (d) with methanol 5. A method of preparing 6-0-benzyl-2,3:4,5-di-0-isopropylidene-myo-inositol H- phosphonate which comprises the steps of: (a) hydrolysis of the 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3:4,5-di-0- isopropylidene-myo-inositol of claim 1 so as to give (-)-δ-O-benzy 1-2,3:4, 5-0- isopropylidene-myo-inositol; and, (b) converting the product of step (a) to 6-0-benzyl-2,3 4,5-dι-O-ιsopropylιdene- myo-mositol H-phosphonate by reaction with PCI3 and imidazole The method of claim 5, wherein the hydrolysis of step (a) is with potassium carbonate in methanol The method of claim 5, wherein (-)-6-0-benzyl-2,3 4,5-O-ιsopropylιdene-myo- inositol is converted by reaction with PCI3 and imidazole A method of preparing enantiomericaliy pure D-myo-inositol 1 ,4,5-trιsphosphate which comprises (a) converting D-myo-inositol to (±)-2,3 4,5-dι-O-ιsopropylιdene-myo-ιnosιtol by the steps of (i) acetonation of myo-inositol so as to give (±)-2,3-0-ιsopropylιdene-myo- inositol, and, (II) acetonation of the product of step (i) so as to give to (±)-2,3 4,5-dι-O- isopropylidene-myo-inositol, (b) converting the product of step (a) to (±)-6-0-benzyl-2,3 4,5-dι-O- isopropylidene by the steps of (i) stannylation of (±)-2,3 4,5-dι-O-ιsopropylιdene-myo-mosιtol, and, (n) benzylation of the product of step (i) so as to give (±)-6-0-benzyl-2,3 4,5- di-O-isopropy dene myo-inositol, (c) converting the product of step (b) to 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl- 2,3 4,5-dι-O-ιsopropylιdene-myo-ιnosιtol, (d) isolation of 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3 4,5-dι-0- isopropy dene-myo-inositol from the product of step (c), (e) converting 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3 4,5-dι-O- isopropylidene-myo-inositol to (+)-6-0-benzyl-2,3-0-ιsopropylιdene myo-inositol by the steps of (i) hydrolysis of 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3 4,5-dι-O- isopropylidene- yo-inositol with pyridinium p-toluenesulfonate so as to give 1-0- [(+)-menthoxycarbonyl]-6-0-benzyl-2,3-0-ιsopropylιdene-myo-ιnosιtol, and, (II) alkaline hydrolysis of the product of step (i) so as to give (+)-6-0-benzyl- 2,3-O-ιsopropylιdene-myo-ιnosιtol, (f) converting the product of step (e) to (-)-6-0-benzyl-2,3-0-ιsopropylιdene-myo- inositol 1 ,4,5-trιs(dιbenzyl phosphate) by the steps of (i) phosphitylation of the product of step (a) so as to give (-)-6-0-benzyl-2,3- 0-ιsopropylιdene-myo-ιnosιtol 1 ,4,5-trιs(dιbenzyl phosphite), (n) in situ oxidation of the product of step (i) so as to give (-)-δ-O-benzy 1-2,3- 0-ιsopropylιdene-myo-ιnosιtol 1 ,4,5-trιs(dιbenzyl phosphate), and, (in) isolation of (-)-6-0-benzyl-2,3-0-ιsopropylιdene-myo-ιnosιtol 1 ,4,5- trιs(dιbenzyl phosphate) from the product of step (n) using S1O2 chromatography, and, (g) converting the product of step (f) to D-myo-inositol 1,4,5-trιsphosphate by the steps of (i) hydrogenolysis of the product of step (b) so as to give D-2,3-0- isopropylidene-myo-inositol 1 ,4,5-trιsphosphate, and, (II) acidification of the product of step (n) so as to give D-myo-inositol 1 ,4,5- tπsphosphate The method of claim 8, wherein the phosphorylation of step (f)(ι) is by reaction with with Λ/,Λ/-dιιsopropyl-dι-benzyl phosphoramidite The method of claim 8, wherein the in situ oxidation of step (f)(ιι) is with m- chloroperoxybenzoic acid ("mCPBA") The method of claim 8, wherein the hydrogenolysis of step (g)(ι) is with palladium on charcoal The method of claim 8, wherein the acidification of step (g)(n) is with acetic acid The method of claim 8, wherein the benzylation of step (b)(ιι) is by reaction with cesium fluoride and benzyl bromide The method of claim 8, wherein the conversion of step (c) is by acylation with (+)- menthyl chloroformate The method of claim 8, wherein 1-0-[(+)-menthoxycarbonyl]-6-0-benzy 1-2,3 4,5- dι-0-ιsopropylιdene-myo-ιnosιtol is recrystallized in step (d) with methanol A method of preparing enantiomericaliy pure L-myo-inositol 1,4,5-tπsphosphate which comprises the steps of (a) hydrolysis of 1-0-[(+)-menthoxycarbonyl]-6-0-benzyl-2,3 4,5-dι-O- isopropylidene-myo-inositol so as to give (-)-6-0-benzyl-2,3 4,5-O-ιsopropylιdene- myo-inositol, (b) converting the product of step (a) to (±)6-0-benzyl-2,3 4,5-dι-O- isopropylidene-myo-inositol H-phosphonate by reaction with PCI3 and imidazole, (c) acylation of (±)-6-0-benzyl-2,3 4,5-dι-0-ιsopropylιdene with (-)-menthyl chloroformate so as to give 3-0-[(+)-menthoxycarbonyl]-4-0-benzyl-1 ,2 5,6-dι-O- isopropylidene-myo-inositol, (d) crystallization of 3-0-[(+)-menthoxycarbonyl]-4-0-benzyl-1 ,2 5,6-dι-O- isopropylidene-myo-inositol from the product of step (c), (e) converting 3-0-[(+)-menthoxycarbonyl]-4-0-benzyl-1 ,2 5,6-dι-O- isopropylidene-myo-inositol to +-4-0-benzyl-1,2-0-ιsopropylιdene-myo-ιnosιtol 3,5,6-trιs(dιbenzyl phosphate) by the steps of (i) phosphitylation of 3-0-[(+)-menthoxycarbonyl]-4-0-benzyl-1 ,2 5,6-dι-O- isopropylidene-myo-inositol so as to give 4-0-benzyl-1 ,2-0-ιsopropylιdene-myo- mositol 3,5,6-trιs(dιbenzyl phosphite), and, (II) in situ oxidation of the product of step (i) so as to give +-4-0-benzyl-1 ,2- 0-ιsopropylιdene-myo-ιnosιtol 3,5,6-trιs(dιbenzyl phosphate), (f) isolation of +-4-0-benzyl-1,2-0-ιsopropylιdene-myo-ιnosιtol 3,5,6-trιs(dιbenzyl phosphate) from the product of step (e), (g) hydrogenolysis of +-4-0-benzyl-1,2-0-ιsopropylιdene-myo-ιnosιtol 3,5,6- tπs(dιbenzyl phosphate) so as to give L-1 ,2-0-ιsopropylιdene-myo-ιnosιtol 3,5,6- tnsphosphate, and, (h)acιdιfιcatιon of L-1 ,2-0-ιsopropylιdene-myo-ιnosιtol 3,5,6-trιsphosphate so as to give L-myo-inositol 3,5,6-trιsphosphate The method of claim 16, wherein 3-0-[(+)-menthoxycarbonyl]-4-0-benzyl-1,2 5,6- dι-0-ιsopropylιdene-myo-ιnosιtol is recrystallized in step (b) using methanol The method of claim 16, wherein the phosphitylation of step (c)(ι) is with N,N- dnsopropyl-dibenzyl phosphoramidite 19. The method of claim 16, wherein the in situ oxidation of step (c)(ii) is with m- chloroperoxybenzoic acid. 20. The method of claim 16, wherein 4-0-benzyl-1 ,2-0-isopropylidene-myo-inositol 3,5,6-tris(dibenzyl phosphate) is isolated in step (d) is using Siθ2 chromatography 21. The method of claim 16, wherein the hydrogenolysis of strep (d) is using palladium on charcoal. 22. The method of claim 16, wherein the acidification of step (f) is with acetic acid. 23. The method of claim 16, wherein the hydrolysis of step (a) is with potassium carbonate in methanol.

Inventors: BITTMAN ROBERT, LEUNG LAWRENCE, BITTMAN, ROBERT, LEUNG, LAWRENCE
Applicants: LIPOSOME CO INC, THE LIPOSOME COMPANY, INC.
Application year: 1998
Main classification: C07D317
IPC codes: C07D317, C07D493, C07F9